FDA inspection
NATCO Pharma Limited: FDA inspection ending Jul 12, 2019
FDA inspection 1103024 · No Action Indicated (NAI) · Chennai
Key facts
| Inspection ID | 1103024 |
|---|---|
| Firm | NATCO Pharma Limited |
| FEI number | 3009870595 |
| Address | 74/7b Manali, Vaikkadu Tpp Salai |
| City | Chennai |
| Country | India |
| Fiscal year | 2019 |
| Inspection end date | Jul 12, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data